Latest Financial Health News

Energy Technologies Limited has secured nearly $2 million through a discounted share placement aimed at reducing debt and shoring up working capital amid ongoing financial restructuring.

AMA Group has initiated an on-market share buy-back program for up to 47.8 million shares, signalling confidence in its financial position and growth strategy without needing shareholder approval.

Judo Bank’s Q3 results show solid lending expansion, stable credit quality amid economic uncertainty, and reaffirmed FY26 guidance with a healthy capital buffer.

Resmed delivered a robust Q3 FY2026 with 11% revenue growth, margin expansion, and a 21% jump in non-GAAP EPS, while announcing a new U.S. distribution centre and a $0.60 dividend.

Orthocell has initiated commercial sales of its Remplir nerve repair device in Canada, leveraging a distributor-led model to penetrate a US$75 million market and setting the stage for broader North American expansion.

Racura Oncology reported robust progress in Q3 FY2026, including launching a key lung cancer trial and unveiling a novel blood test for cardioprotection, supported by a solid $19.38 million cash position.

Dubber Corporation reported a historic positive underlying operating cashflow run-rate in Q3 FY26, driven by a USD 3.06 million initial payment from a Tier 1 North American communications service provider and ongoing cost reductions. Recurring revenue dipped 6% quarter-on-quarter due to portfolio optimisation and foreign exchange impacts.

EMC Gold is pushing forward with a drilling campaign at its Salave Gold Project while navigating a procedural setback from the High Court of Asturias. The company also surrendered its Ivan Well tenement in WA and maintains a solid cash position of CAD$4.6 million.

Culpeo Minerals has restructured its Lana Corina earn-in deal to slash near-term cash outlays and plans a fully funded 4,000m diamond drilling campaign at Vista Montana in Q2 2026, while advancing its Fortuna copper project and streamlining its shareholder base.

Resonance Health reports strong cash flow and progress in clinical trials, with a record forward order pipeline for its Software-as-a-Medical-Device business and profitable trial site clinics.

Australian Agricultural Projects is poised for its 2026 olive harvest with upgraded equipment and has reduced borrowings despite early March flooding. Cash flow remains strong, though a seasonal deficit looms.

Castile Resources has kicked off pilot plant bench scale testing for its Rover 1 project, integrating a 41% resource upgrade and higher metal prices into its Bankable Feasibility Study. The company also secured $8.4 million in funding and is preparing for exploration drilling amid regional consolidation.